Technical Analysis for MPH - Mereo Biopharma Group Limited

Grade Last Price % Change Price Change
grade F 32.0 -7.25% -2.50
MPH closed down 7.25 percent on Friday, January 17, 2020, on approximately normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical MPH trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Calm After Storm Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -7.25%
Calm After Storm Range Contraction -7.25%
Narrow Range Bar Range Contraction -7.25%
NR7 Range Contraction -7.25%
Wide Bands Range Expansion -7.25%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -5.88%
20 DMA Support Bullish -5.88%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Mereo BioPharma Group plc is a United Kingdom-based specialty biopharmaceutical company. The Company is engaged in the research and development of pharmaceuticals. It operates through three segments: Respiratory Unit, Endocrinology Disorders Unit and Orphan Diseases Unit. The Respiratory Unit segment develops drugs to treat respiratory diseases. The Endocrinology Disorders Unit segment develops drugs to treat endocrine disorders. The Orphan Diseases Unit segment develops drugs to treat various orphan diseases. It is engaged in the Phase II dose-ranging study with its oral anti-inflammatory agent, BCT-197, for treatment of the underlying inflammation in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Its product candidate, BPS-804, is in Phase II b/III study in patients with osteogenesis imperfecta (OI). It has initiated a Phase II b study with its oral aromatase inhibitor BGS-649 for the treatment of hypogonadal hypogonadism (HH) in obese men.
Chemistry Physical Sciences Pharmaceuticals Pharmaceutical Industry Biopharmaceutical Health Sciences Chronic Obstructive Pulmonary Disease Respiratory Diseases Medication Inflammation Organofluorides

Is MPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 320.0
52 Week Low 23.5
Average Volume 313,112
200-Day Moving Average 74.35
50-Day Moving Average 36.93
20-Day Moving Average 33.68
10-Day Moving Average 34.80
Average True Range 5.69
ADX 28.44
+DI 30.83
-DI 20.12
Chandelier Exit (Long, 3 ATRs ) 37.44
Chandelier Exit (Short, 3 ATRs ) 40.56
Upper Bollinger Band 46.81
Lower Bollinger Band 20.54
Percent B (%b) 0.44
BandWidth 77.99
MACD Line -0.60
MACD Signal Line -0.64
MACD Histogram 0.0457
Fundamentals Value
Market Cap 42.43 Thousand
Num Shares 1.33 Thousand
EPS 13.00
Price-to-Earnings (P/E) Ratio 2.46
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 1.50
Dividend Yield 4.69%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 37.25
Resistance 3 (R3) 37.57 36.13 36.38
Resistance 2 (R2) 36.13 34.80 35.98 36.08
Resistance 1 (R1) 34.07 33.97 33.35 33.75 35.79
Pivot Point 32.63 32.63 32.28 32.48 32.63
Support 1 (S1) 30.57 31.30 29.85 30.25 28.21
Support 2 (S2) 29.13 30.47 28.98 27.92
Support 3 (S3) 27.07 29.13 27.63
Support 4 (S4) 26.75